New developments in the analysis of gene expression

被引:19
作者
Burgess, JK
Hazelton, RH
机构
[1] Univ Sydney, Dept Pharmacol, Resp Res Grp, Sydney, NSW 2006, Australia
[2] Univ Sydney, Dept Pathol, Resp Res Grp, Sydney, NSW 2006, Australia
关键词
D O I
10.1179/135100000101535348
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An understanding of the relationship between gene expression, protein expression and the influences of genetic responses upon gene function is vital before we can understand the complexity of genomes, Traditional methods for the study of gene expression are limited to studying small groups of genes at a time and a source of pure starting material has been difficult to obtain. Recent technological advances have enabled large numbers of genes, from specific cell populations, to be studied in a single experiment. Laser capture microdissection (LCM) and microarray technology are providing the next revolution in the study of gene expression. LCM-based molecular analysis of histopathological lesions can be applied to any disease process that is accessible through tissue sampling. Examples include: (i) mapping the field of genetic changes associated with oxidative stress, (ii) analysis of gene expression patterns in atherosclerotic tissues, sites of inflammation and Alzheimer's disease plaques; (iii) infectious micro-organism diagnosis; and (iv) typing of cells within disease foci. Microarray hybridisation glass chips spotted with sets of genes can then be used to obtain a molecular fingerprint of gene expression in the microdissected cells. The variation of expressed genes or alterations in the cellular DNA that correlate with a particular disease state can be compared within or between individual samples. The identification of gene expression patterns may provide vital information for the understanding of the disease process and may contribute to diagnostic decisions and therapies tailored to the individual patient. Molecules found to be associated with defined pathological lesions may provide clues about new therapeutic targets in the future.
引用
收藏
页码:63 / 73
页数:11
相关论文
共 70 条
  • [1] Abati A, 1999, CANCER CYTOPATHOL, V87, P231, DOI 10.1002/(SICI)1097-0142(19990825)87:4<231::AID-CNCR11>3.3.CO
  • [2] 2-1
  • [3] COMPLEMENTARY-DNA SEQUENCING - EXPRESSED SEQUENCE TAGS AND HUMAN GENOME PROJECT
    ADAMS, MD
    KELLEY, JM
    GOCAYNE, JD
    DUBNICK, M
    POLYMEROPOULOS, MH
    XIAO, H
    MERRIL, CR
    WU, A
    OLDE, B
    MORENO, RF
    KERLAVAGE, AR
    MCCOMBIE, WR
    VENTER, JC
    [J]. SCIENCE, 1991, 252 (5013) : 1651 - 1656
  • [4] METHOD FOR DETECTION OF SPECIFIC RNAS IN AGAROSE GELS BY TRANSFER TO DIAZOBENZYLOXYMETHYL-PAPER AND HYBRIDIZATION WITH DNA PROBES
    ALWINE, JC
    KEMP, DJ
    STARK, GR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (12) : 5350 - 5354
  • [5] Banks RE, 1999, ELECTROPHORESIS, V20, P689, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<689::AID-ELPS689>3.0.CO
  • [6] 2-J
  • [7] Becker I, 1996, LAB INVEST, V75, P801
  • [8] BERNS MW, 1991, INT REV CYTOL, V129, P1
  • [9] Bernsen MR, 1998, LAB INVEST, V78, P1267
  • [10] A MICRODISSECTION APPROACH TO DETECT MOLECULAR MARKERS DURING PROGRESSION OF PROSTATE-CANCER
    BERTHON, P
    DIMITROV, T
    STOWER, M
    CUSSENOT, O
    MAITLAND, NJ
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (04) : 946 - 951